Portfolio company
BioCrine AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops diabetes treatments and in-vivo imaging technology for pharmaceutical and biotechnology partners and academic researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BioFactor Therapeutics AB
This pharmaceutical developer creates recombinant protein therapies for patients with metabolic and endocrine disorders.
GutCRINE
This company develops microbiome-derived pharmabiotics to treat metabolic and age-related disorders including obesity and type-2 diabetes for patients with chronic diseases.
Bioinvent
This clinical-stage biotechnology company develops antibody-based therapies for cancer treatment for pharmaceutical partners and produces drug substances for clinical trials.
Antaros Medical
This company provides medical imaging solutions and clinical trial delivery services for pharmaceutical businesses involved in drug development.
Aqilion
This biotech company develops early-stage drug treatments for chronic inflammatory diseases to supply pharmaceutical and biotechnology partners with new clinical development projects.
Toralgen
This biopharmaceutical company develops nanoparticle technology for the oral delivery of biologics and diabetes medications for pharmaceutical partners and patients.
AdipoPharma SAS
This biotech company develops a therapeutic peptide to treat insulin resistance and type 2 diabetes for patients with metabolic diseases.
Bioinvent International
This company develops antibody-based immunotherapies for cancer patients and provides contract manufacturing services to pharmaceutical firms and academic institutions.